- Trials with a EudraCT protocol (475)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (31)
475 result(s) found for: Vein.
Displaying page 1 of 24.
EudraCT Number: 2012-000800-13 | Sponsor Protocol Number: V1 | Start Date*: 2013-01-24 | |||||||||||||||||||||
Sponsor Name:Universitätsklinik für Augenheilkunde und Optometrie | |||||||||||||||||||||||
Full Title: Influence of sustained-release dexamethasone on intraocular cytokines and growth factors and retinal blood vessels in retinal vein occlusion | |||||||||||||||||||||||
Medical condition: Retinal vein occlusion | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: AT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-004656-38 | Sponsor Protocol Number: CRF002EVA | Start Date*: 2015-03-11 | ||||||||||||||||
Sponsor Name:Prof. Dr. Karl-Heinz Emmerich | ||||||||||||||||||
Full Title: Assessment of the suitability of serum VEGF level as diagnostic factor in macula edema caused by retinal or central retinal vein occlusion under therapy with Lucentis® (ranibizumab) | ||||||||||||||||||
Medical condition: Central retinal vein occlusion Retinal vein occlusion | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001190-40 | Sponsor Protocol Number: P110150 | Start Date*: 2018-05-16 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003374-24 | Sponsor Protocol Number: OP-2005-01 | Start Date*: 2005-09-12 | |||||||||||
Sponsor Name:OPOCRIN S.P.A. | |||||||||||||
Full Title: A phase 2, controlled, multi-center pilot study to evaluate the efficacy and safety of Deligoparin in subjects with retinal vein occlusion of recent onset. | |||||||||||||
Medical condition: Treatment of retinal vein occlusion. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011403-23 | Sponsor Protocol Number: CHIC2009-01 | Start Date*: 2009-08-10 | |||||||||||
Sponsor Name:Centre Hospitalier Intercommunal de Créteil | |||||||||||||
Full Title: ETUDE PILOTE SUR L’EFFICACITE ET LA TOLERANCE DES INJECTIONS INTRA-VITREENNES DE LUCENTIS (RANIBIZUMABÒ) A LA PHASE INITIALE DES OCCLUSIONS DE LA VEINE CENTRALE DE LA RETINE | |||||||||||||
Medical condition: Central retinal vein occlusion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004826-28 | Sponsor Protocol Number: ict-bem-2004-02 | Start Date*: 2005-03-28 | |||||||||||
Sponsor Name:Instituto Científico y Tecnológico de Navarra | |||||||||||||
Full Title: Multicenter double-blind placebo controlled aleatorized study to evaluate the efficacy and safety of bemiparin (3500 IU/day) in thromboprophylaxis in cancer paients with central vein catheter | |||||||||||||
Medical condition: Deep Vein Thrombosis related central vein catheter (DVT-CVC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002790-11 | Sponsor Protocol Number: V4.0 | Start Date*: 2015-06-08 | ||||||||||||||||
Sponsor Name:Ludwig-Maximilians Universität München | ||||||||||||||||||
Full Title: Evaluation of additional peripheral panretinal LASER-treatment on recurrences of macular edema due to CRVO undergoing anti-VEGF treatment with ranibizumab | ||||||||||||||||||
Medical condition: | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000165-20 | Sponsor Protocol Number: OZUROFT01/12 | Start Date*: 2012-04-13 | |||||||||||
Sponsor Name:Fundación para la Investigación biomédica del Hospital Universitario Ramón y Cajal. Madrid | |||||||||||||
Full Title: SEQUENTIAL CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF INTRAVITREAL BEVACIZUMAB AS RESCUE TREATMENT OF RECURRENT MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH OZURDEX | |||||||||||||
Medical condition: Macular edema secondary to retinal vein occlusion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000440-63 | Sponsor Protocol Number: GR41984 | Start Date*: 2020-09-30 | |||||||||||
Sponsor Name:F.Hoffmann La-Roche Ltd | |||||||||||||
Full Title: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, ACTIVE COMPARATOR-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FARICIMAB IN PATIENTS WITH MACULAR EDEMA SECONDARY TO BRANCH RETINAL ... | |||||||||||||
Medical condition: Macular edema secondary to Branch Retinal Vein Occlusion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) PT (Completed) AT (Completed) CZ (Completed) PL (Completed) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017782-30 | Sponsor Protocol Number: Lucentis in CRVO | Start Date*: 2010-03-22 | ||||||||||||||||
Sponsor Name:Medizinische Universität Graz, Universitäts-Augenklinik | ||||||||||||||||||
Full Title: Treatment of macular edema due to central retinal vein occlusion with ranibizumab (Lucentis®). | ||||||||||||||||||
Medical condition: This case-series is designed to evaluate the safety and efficacy of intravitreal ranibizumab (Lucentis®) in the treatment of macular edema due to central retinal vein occlusion. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-007175-24 | Sponsor Protocol Number: CRFB002AHU02T | Start Date*: 2009-02-06 | |||||||||||
Sponsor Name:University of Pécs, Medical School, Department of Ophthalmology | |||||||||||||
Full Title: A randomized, controlled, two-center phase II. study assessing the efficacy and safety of intravitreal Lucentis injections in patients with clinically significant macular edema secondary to central... | |||||||||||||
Medical condition: Macular edema secondary to central retinal vein occlusion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003762-18 | Sponsor Protocol Number: 2007.468/11 | Start Date*: 2008-10-23 | |||||||||||
Sponsor Name:Hospices Civils de Lyon | |||||||||||||
Full Title: Prospective monocenter accuracy study of Vasovist contrast enhanced magnetic resonance venography (CE-MRV) to detect venous thrombi in patients with Ultrasonography detected peripheral acute deep ... | |||||||||||||
Medical condition: Acute deep vein thrombosis (DVT) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002502-29 | Sponsor Protocol Number: 206207-009 | Start Date*: 2004-12-08 |
Sponsor Name:Allergan Limited | ||
Full Title: A Six-Month Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial (with Six-Month Open-Label Extension) to Assess the Safety and Efficacy of 700 µg and 350 µg Dexamethasone Posterior Segm... | ||
Medical condition: Macular edema due to Branch Retinal Vein Occlusion (BRVO) or Central Retinal Vein Occlusion (CRVO) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) IT (Completed) HU (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-003240-37 | Sponsor Protocol Number: TROMBOXABAN | Start Date*: 2017-02-20 |
Sponsor Name:Fundación para la Investigación Biomédica Hospital Ramón y Cajal | ||
Full Title: Prospective, multicenter, randomized study to assess the effect of rivaroxaban in the portal vein thrombosis recanalization and the survival in patients with cirrhosis and portal vein thrombosis | ||
Medical condition: Liver cirrhosis and portal vein thrombosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002730-11 | Sponsor Protocol Number: A091031 | Start Date*: 2007-11-30 | |||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust | |||||||||||||
Full Title: Magnetic resonance (MR) angiography with a blood pool contrast medium. | |||||||||||||
Medical condition: Abnormalities of the major venous system. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2023-000170-97 | Sponsor Protocol Number: 2023-01-1200-01 | Start Date*: 2023-06-30 | |||||||||||
Sponsor Name:LMU Universitätsklinikum München | |||||||||||||
Full Title: A single dose of apixaban for the prevention of thrombotic events in the context of long-distance flights | |||||||||||||
Medical condition: Symptomatic leg vein thrombosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000681-42 | Sponsor Protocol Number: CoRaLa_II | Start Date*: 2020-08-24 | ||||||||||||||||
Sponsor Name:Justus-Liebig University Gießen | ||||||||||||||||||
Full Title: Long-term need of ranibizumab injections with or without early targeted peripheral laser photocoagulation for treatment of macular edema due to central retinal vein occlusion | ||||||||||||||||||
Medical condition: Macular edema due to central retinal vein occlusion | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Trial now transitioned) AT (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000441-13 | Sponsor Protocol Number: GR41986 | Start Date*: 2020-08-27 | |||||||||||
Sponsor Name:F.Hoffmann La-Roche Ltd | |||||||||||||
Full Title: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, ACTIVE COMPARATOR-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FARICIMAB IN PATIENTS WITH MACULAR EDEMA SECONDARY TO CENTRAL RETINAL ... | |||||||||||||
Medical condition: Macular edema secondary to Central Retinal or Hemiretinal Vein Occlusion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PT (Completed) AT (Completed) CZ (Completed) HU (Completed) FR (Completed) PL (Completed) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005789-30 | Sponsor Protocol Number: IOBA-03-2008 | Start Date*: 2009-04-22 | ||||||||||||||||
Sponsor Name:María Isabel López Gálvez-Instituto Universitario de Oftalmobiología Aplicada-Universidad Valladolid | ||||||||||||||||||
Full Title: Estudio de la eficacia y seguridad de inyecciones intravítreas de bevacizumab en el edema macular secundario a oclusiones venosas retinianas (EBOVER) | ||||||||||||||||||
Medical condition: Edema macular secundario a oclusiones venosas retinianas | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-005524-13 | Sponsor Protocol Number: I-ICRNS-005-PRCLD-DVT-01 | Start Date*: 2006-03-22 | |||||||||||
Sponsor Name:CRINOS S.p.A. | |||||||||||||
Full Title: Defibrotide in the prevention of recurrences in venous thrombosis: DEPRIVE. A randomised, multicentre, European, double blind, parallel group study, to assess the efficacy and tolerability of defib... | |||||||||||||
Medical condition: DVT and PE are part of the same disease that can be defined Venous Thromboembolism (VTE). Treatment of the acute phases is well established: LMWH during the first days and OAT for 3-12 months. Afte... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.